J&J, Wyeth Fail to Revive Cardiac Stent Patent Claims

, The Litigation Daily

   |0 Comments

A Federal Circuit panel has upheld a summary judgment that dismissed an infringement suit brought by Johnson & Johnson and Wyeth LLC and invalidated the cardiac stent patents at issue. The ruling is a win for defendants Abbott Laboratories and Medtronic, represented by McAndrews, Held & Malloy and McKool Smith, and defendant Boston Scientific, represented by Arnold & Porter.

This article has been archived, and is no longer available on this website.

View this content exclusively through LexisNexis® Here

Not a LexisNexis® Subscriber?

Subscribe Now

Why am I seeing this?

LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® customers will be able to access and use ALM's content by subscribing to the LexisNexis® services via lexis.com® and Nexis®. This includes content from The National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.

ALM's content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.

For questions call 1-877-256-2472 or contact us at customercare@alm.com

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202608707396

Thank you!

This article's comments will be reviewed.